top of page

SFTCG annual meeting, Lyon - 16-18 March 2022

SFTCG would like to congratulate this year's oral and poster presentation award winners, who presented at the 2022 Annual Meeting in Lyon.

Oral Presentation Winners

Juliette Rosier, Université Bordeaux CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells leading to imprinting defects

Celia Sourd, Genethon, UMR_S951, Inserm, Univ Evry, Université Paris Saclay, EPHE An AAVpo1A1 vector expressing MTM1 corrects skeletal muscle pathology with detargeted liver transduction in myotubular myopathy mice

Tina Briolay, Université de Nantes Development of a bio-inspired nanovector for targeted cancer gene therapy

Ugo Hirigoyen, Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA Characterization of tumor extracellular vesicles produced during oncolytic infection

Poster Presentation Winners

Alejandra Gutierrez, CIRI; Inserm U1111, ENS Lyon, France Chemically surface modified AAV6 vectors combined with nanoblades are a promising alternative for gene knock-in in HSCs

Mathilde Beaufils, Univ. Grenoble Alpes Inserm U1216 CHU Grenoble Alpes Grenoble Institut Neurosciences Development of knock-out muscle cell line using lentivirus-mediated CRISPR/Cas 9 gene editing: application to RYR1 gene

Guillaume Wurtz, Universite Paris Sud; Université Sorbonne Paris Cité; Institut du Cerveau et de la Moelle épiniere; Inserm Modulation of cholesterol metabolism as a new therapeutical approach for amyotrophic lateral sclerosis


bottom of page